Annual Net Margin
-37.98%
+47.88%+55.77%
31 December 2023
Summary:
Xeris Biopharma Holdings annual net profit margin is currently -37.98%, with the most recent change of +47.88% (+55.77%) on 31 December 2023. During the last 3 years, it has risen by +408.02% (+91.48%). XERS annual net margin is now at all-time high.XERS Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
-29.00%
+2.22%+7.11%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly net profit margin is currently -29.00%, with the most recent change of +2.22% (+7.11%) on 30 September 2024. Over the past year, it has dropped by -3.77% (-14.94%). XERS quarterly net margin is now -14.94% below its all-time high of -25.23%, reached on 30 September 2023.XERS Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Net Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +55.8% | -14.9% |
3 y3 years | +91.5% | +87.7% |
5 y5 years | +98.5% | +99.7% |
XERS Net Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +91.5% | -14.9% | +87.8% |
5 y | 5 years | at high | +99.2% | -14.9% | +99.7% |
alltime | all time | at high | +99.2% | -14.9% | +99.8% |
Xeris Biopharma Holdings Net Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -29.00%(-7.1%) |
June 2024 | - | -31.22%(-33.2%) |
Mar 2024 | - | -46.71%(+54.9%) |
Dec 2023 | -37.98%(-55.8%) | -30.16%(+19.5%) |
Sept 2023 | - | -25.23%(-51.7%) |
June 2023 | - | -52.20%(+2.9%) |
Mar 2023 | - | -50.71%(+30.0%) |
Dec 2022 | -85.86%(-65.3%) | -39.01%(-46.9%) |
Sept 2022 | - | -73.44%(-29.0%) |
June 2022 | - | -103.47%(-32.3%) |
Mar 2022 | - | -152.74%(-35.6%) |
Dec 2021 | -247.48%(-44.5%) | -237.02%(+0.8%) |
Sept 2021 | - | -235.16%(-23.9%) |
June 2021 | - | -308.95%(+37.5%) |
Mar 2021 | - | -224.66%(-24.3%) |
Dec 2020 | -446.00% | -296.61%(+74.3%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | -170.14%(-85.7%) |
June 2020 | - | -1188.90%(-31.7%) |
Mar 2020 | - | -1741.29%(-1.9%) |
Dec 2019 | -4613.52%(+86.1%) | -1774.79%(-83.1%) |
Sept 2019 | - | -10.49 K%(-9.4%) |
June 2019 | - | -11.58 K%(+13.6%) |
Mar 2019 | - | -10.19 K%(+278.9%) |
Dec 2018 | -2479.57%(+45.3%) | -2690.25%(+6.0%) |
Sept 2018 | - | -2537.29%(+60.0%) |
June 2018 | - | -1585.71%(-65.0%) |
Mar 2018 | - | -4527.38%(+131.2%) |
Dec 2017 | -1706.56%(+38.9%) | -1958.46%(-55.8%) |
Sept 2017 | - | -4427.65%(+378.1%) |
June 2017 | - | -926.02%(-29.5%) |
Mar 2017 | - | -1313.28% |
Dec 2016 | -1228.74% | - |
FAQ
- What is Xeris Biopharma Holdings annual net profit margin?
- What is the all time high annual net margin for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual net margin year-on-year change?
- What is Xeris Biopharma Holdings quarterly net profit margin?
- What is the all time high quarterly net margin for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly net margin year-on-year change?
What is Xeris Biopharma Holdings annual net profit margin?
The current annual net margin of XERS is -37.98%
What is the all time high annual net margin for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual net profit margin is -37.98%
What is Xeris Biopharma Holdings annual net margin year-on-year change?
Over the past year, XERS annual net profit margin has changed by +47.88% (+55.77%)
What is Xeris Biopharma Holdings quarterly net profit margin?
The current quarterly net margin of XERS is -29.00%
What is the all time high quarterly net margin for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly net profit margin is -25.23%
What is Xeris Biopharma Holdings quarterly net margin year-on-year change?
Over the past year, XERS quarterly net profit margin has changed by -3.77% (-14.94%)